Vaccines


Updated Vaccines for Fall 2023

  • Recommended age groups, doses, and timeline: CDC Guide. 10/4/2023
  • "What to Know About the Updated COVID-19 Vaccine for Fall/Winter 2023" (Article from Johns Hopkins School of Public Health, 9/14/2023)

    Moderna and Pfizer-BioNTech
    • mRNA-based vaccine made to target omicron variant XBB.1.5
      • Also expected to be effective against more recent virus strains, including EG.5 and BA.2.86
    • Most widely available vaccine in the US currently (as of 10/6)
    • authorized in the US for individuals 5yrs and up
    Novavax
    • Protein-based vaccine made to target omicron variant XBB.1.5
      • Also expected to be effective against more recent virus strains
    • "The Novavax vaccine [was built with] a much older technology for vaccine development where, instead of injecting the genetic recipe, we actually inject the protein. It [uses] a combination of spike proteins that form what are called nanoparticles, which group together. The Novavax vaccine also has an adjuvant, an immune stimulant to get a better immune response."Article from Johns Hopkins School of Public Health. July 2022.
    • Authorized in the US for individuals 12yrs and up